论文部分内容阅读
血管活性药物治疗肺心病近年来已有较多报告,临床适应证为肺心病并心衰.我们自1987年3月至1989年3月在综合治疗基础上加苄胺唑啉、多巴胺(简称苄多合剂)治疗肺心病急性发作32例,同时以28例仅用综合治疗作为对照,观察两组临床表现的转归
Vasoactive drug treatment of pulmonary heart disease in recent years have been more reports, clinical indications for pulmonary heart disease and heart failure .We from March 1987 to March 1989 on the basis of comprehensive treatment plus benzyl amine, dopamine (referred to as benzyl Multi-agent) in the treatment of acute pulmonary heart disease in 32 cases, while only 28 cases of comprehensive treatment as a control to observe the clinical outcome of the two groups